Bonviva

Bonviva is a brand of ibandronate, a medication used to treat and prevent osteoporosis, a condition in which bones become weak and brittle. The brand is produced by Roche, a global pharmaceutical company.

Ibandronate is a type of bisphosphonate medication that works by slowing down the activity of cells that break down bone tissue. This helps to increase bone density and reduce the risk of fractures. Bonviva is available in two formulations: an oral tablet and an intravenous injection.

The oral tablet is taken once a month, while the intravenous injection is given once every three months by a healthcare professional. The choice of formulation depends on the individual patient’s preference and medical history.